Literature DB >> 21175592

Clinical immunology review series: an approach to desensitization.

M T Krishna1, A P Huissoon.   

Abstract

Allergen immunotherapy describes the treatment of allergic disease through administration of gradually increasing doses of allergen. This form of immune tolerance induction is now safer, more reliably efficacious and better understood than when it was first formally described in 1911. In this paper the authors aim to summarize the current state of the art in immunotherapy in the treatment of inhalant, venom and drug allergies, with specific reference to its practice in the United Kingdom. A practical approach has been taken, with reference to current evidence and guidelines, including illustrative protocols and vaccine schedules. A number of novel approaches and techniques are likely to change considerably the way in which we select and treat allergy patients in the coming decade, and these advances are previewed.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21175592      PMCID: PMC3043304          DOI: 10.1111/j.1365-2249.2010.04296.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  143 in total

1.  Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings.

Authors:  D Ludolph-Hauser; F Ruëff; C Fries; P Schöpf; B Przybilla
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

2.  Imipenem in patients with immediate hypersensitivity to penicillins.

Authors:  Antonino Romano; Marinella Viola; Rosa-Maria Guéant-Rodriguez; Francesco Gaeta; Rosa Pettinato; Jean-Louis Guéant
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

3.  Anaphylaxis to sublingual immunotherapy.

Authors:  E H Dunsky; M F Goldstein; D J Dvorin; G A Belecanech
Journal:  Allergy       Date:  2006-10       Impact factor: 13.146

4.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

Authors:  Christian Möller; Sten Dreborg; Hosne A Ferdousi; Susanne Halken; Arne Høst; Lars Jacobsen; Antti Koivikko; Dieter Y Koller; Bodo Niggemann; Lene A Norberg; Radvan Urbanek; Erkka Valovirta; Ulrich Wahn
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

5.  A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections.

Authors:  K J Drachenberg; A W Wheeler; P Stuebner; F Horak
Journal:  Allergy       Date:  2001-06       Impact factor: 13.146

6.  Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

Authors:  David I Bernstein; Mark Wanner; Larry Borish; Gary M Liss
Journal:  J Allergy Clin Immunol       Date:  2004-06       Impact factor: 10.793

7.  Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells.

Authors:  L K Wilcock; J N Francis; S R Durham
Journal:  Clin Exp Allergy       Date:  2004-09       Impact factor: 5.018

8.  Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.

Authors:  Joanne N G Oude Elberink; Jan G R De Monchy; Sicco Van Der Heide; Gordon H Guyatt; Anthony E J Dubois
Journal:  J Allergy Clin Immunol       Date:  2002-07       Impact factor: 10.793

9.  Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.

Authors:  Anthony J Frew; Richard J Powell; Christopher J Corrigan; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

10.  Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

Authors:  Gabrielle Pauli; Tina H Larsen; Sabina Rak; Friedrich Horak; Elide Pastorello; Rudolf Valenta; Rudolph Valenta; Ashok Purohit; Monica Arvidsson; Alexander Kavina; Jan W Schroeder; Nadine Mothes; Susanne Spitzauer; Armelle Montagut; Sylvie Galvain; Michel Melac; Claude André; Lars K Poulsen; Hans-Jorgen Malling
Journal:  J Allergy Clin Immunol       Date:  2008-11       Impact factor: 10.793

View more
  19 in total

1.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

2.  rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant.

Authors:  Claudia Petrarca; Emanuela Clemente; Valentina Toto; Manuela Iezzi; Cosmo Rossi; Stefania Zanotta; Gianni Mistrello; Ivan Zanoni; Francesca Granucci; Stefania Arioli; Diego Mora; Simone Guglielmetti; Roberto Paganelli; Mario Di Gioacchino
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

Review 3.  Linking autoantigen properties to mechanisms of immunity.

Authors:  J Daniel Griffin; Jimmy Y Song; Joshua O Sestak; Brandon J DeKosky; Cory J Berkland
Journal:  Adv Drug Deliv Rev       Date:  2020-04-20       Impact factor: 15.470

Review 4.  Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy.

Authors:  T Mousallem; A W Burks
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 5.  Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation.

Authors:  S U Patil; W G Shreffler
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 6.  Future therapies for food allergy.

Authors:  Laurie M McWilliams; Talal Mousallem; A Wesley Burks
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

7.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 8.  Novel approaches to food allergy.

Authors:  Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

9.  Curative effect of 18β-glycyrrhetinic acid in experimental visceral leishmaniasis depends on phosphatase-dependent modulation of cellular MAP kinases.

Authors:  Anindita Ukil; Susanta Kar; Supriya Srivastav; Kuntal Ghosh; Pijush K Das
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 10.  Immunotherapy (oral and sublingual) for food allergy to fruits.

Authors:  Juan Jose Yepes-Nuñez; Yuan Zhang; Marta Roqué i Figuls; Joan Bartra Tomas; Juan Manuel Reyes; Fernando Pineda de la Losa; Ernesto Enrique
Journal:  Cochrane Database Syst Rev       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.